| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.1M | — | +1572.1% |
| Cost of Revenue | $108K | — | +260.0% |
| R&D Expense | $12.8M | — | -16.6% |
| SG&A Expense | $9.2M | — | -20.5% |
| Operating Income | -$996K | — | +96.1% |
| Net Income | -$1.0M | — | +95.9% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.1M | +11.0% | -39.4% |
| Short-term Investments | $132.6M | +114.2% | +0.5% |
| Accounts Receivable | $11.8M | +394.1% | -75.2% |
| Inventory | $276K | -1.8% | +37.3% |
| Current Assets | $186.0M | +82.6% | -24.3% |
| Total Assets | $268.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.7M | — | +66.4% |
| Investing Cash Flow | -$70.3M | — | -273.1% |
| Financing Cash Flow | $88.8M | — | — |
| -9.7% |
| Current Liabilities | $9.9M | -52.6% | -91.1% |
| Long-term Debt | $49.7M | +0.6% | -15.3% |
| Total Liabilities | $66.0M | -14.8% | -62.2% |
| Stockholders' Equity | $202.9M | +88.6% | +64.9% |